Publication | Open Access

Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity

Metabolic SyndromeMedicinal ChemistryLipid SynthesisBiochemistryMedicineNatural SciencesDiabetesPharmacological AgentPharmacotherapyHepatic SteatosisThiazole-4-acetic Acid DerivativesDrug DevelopmentFatty Liver DiseasePharmacologyPharmaceutical ChemistryDrug Discovery